Business
Groupe Athena, Inc. Releases 3rd Quarter Financials, Continues Strong Revenue And Earnings Growth
Groupe Athena, Inc. Releases 3rd Quarter Financials, Continues Strong Revenue And Earnings Growth.
About this update from Ayujoy Herbals Ltd.
[{"type":"text","content":"\n\n\n\n\n\n\n\nGroupe Athena, Inc. Releases 3rd Quarter Financials, Continues Strong Revenue And Earnings Growth\n\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:\"0in\";\n}\n\n\n\n\n\n\n\n\n\n\nGroupe Athena, Inc. Releases 3rd Quarter Financials, Continues Strong Revenue And Earnings Growth\n\nPR Newswire\n\nMUMBAI, India, April 10, 2013\n\n\n\n\n\n\n\nMUMBAI, India, April 10, 2013 /PRNewswire/ -- Groupe Athena, Inc. (OTCPink: GATA) today released their quarterly report for the three months ending March 30, 2013. Revenues for the period were $13,378,452 which represents a 29% increase over the same period in 2012. Net after tax income for the period was $1,319,920 or $.03 per share.\n\n\nCumulative revenue for the trailing twelve months (ttm) was $53,569,759 with per share earnings of $.11 per share. \n\n\nCash reserves remain strong and continue to grow and long term debt remains virtually non-existent as the Company prepares to outfit its recently purchased new testing facility. The company reports it is still committed to funding all capital expenditures entirely from internal cash accruals without any shareholder dilution or debt increases. \n\n\nCompany Chairman, D. Purohit stated, \"At Groupe Athena we strive to create shareholder value as a component of our business model and our current price to earnings ratio and share valuation is a fraction of our industry peers which is indicative of those efforts. The Indian pharmaceutical industry continues to be a global leader and experience superior growth which is creating new pathways for Groupe Athena to follow.\" \n\n\nAs previously stated, the company plans to apply for listing on the NASDAQ Bulletin Board quotation system with the completion of the audit for this fiscal year ending June 30, 2013. \n\n\nTo review the complete quarterly report please go to www.otcmarkets.com/stock/GATA/quote and click on \"Financials\"\n\n\nThe Indian pharmaceutical industry is increasingly focusing on exports to the United States and GATA is well positioned to help them get their products approved by the FDA for sales in the US. All of these are pote...